Sterne Kessler Files 11 IPRs on Behalf of GeneDx, Inc., Subsidiary of Bioreference Laboratories, Inc.

Sterne Kessler announced today that it has filed eleven petitions for Inter Partes Review (IPR) with the U.S. Patent and Trademark Office (USPTO) on behalf of GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc. (Nasdaq:BRLI). These IPR petitions aim to nullify eleven patents owned, co-owned, or licensed by Myriad Genetics, Inc. These patents have been asserted against GeneDx in patent infringement litigation initiated in the United States District Court for the District of Utah on October 17, 2013.

To read our full press release, download the attached PDF.